Quantcast

Latest Diagnostic tests Stories

2010-06-09 15:31:00

QUEBEC CITY, June 9 /PRNewswire-FirstCall/ - DiagnoCure, Inc. (TSX: CUR), a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services, today reported financial and operation results for the second quarter 2010 ended April 30, 2010.

2010-06-06 07:00:00

SAN DIEGO, June 6 /PRNewswire/ -- bioTheranostics, a bioMerieux company that develops innovative oncology diagnostic tests to drive personalized treatment, reported today findings from clinical studies utilizing the company's CancerTYPE ID® and Breast Cancer Index® molecular oncology tests.

2010-06-04 01:01:00

BEIJING, June 4 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc.

2010-04-13 08:15:00

DENVER, April 13 /PRNewswire-FirstCall/ -- Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostic test kits, including innovative products for emerging pathogens and lethal viruses, today announced a major extension of the collaborative effort to combat important viral diseases. The National Institutes of Health (NIH) has awarded a grant totaling $600,000 to Corgenix for the two-year study, which will focus on development of novel,...

2010-04-12 05:30:00

QUEBEC CITY and WEST CHESTER, PA, April 12 /PRNewswire-FirstCall/ - DiagnoCure, Inc. (TSX: CUR), a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services, has appointed Ms.

2010-03-17 13:30:00

QUEBEC CITY, March 17 /PRNewswire-FirstCall/ - DiagnoCure, Inc. (TSX: CUR), a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services, today reported financial and operation results for the first quarter 2010 ended January 31, 2010.

2010-03-04 07:00:00

SAN DIEGO, Calif., March 4 /PRNewswire/ -- bioTheranostics, a bioMerieux company that discovers, develops and commercializes innovative molecular diagnostic tests in oncology, announces the launch of an expanded tumor-type database for its flagship product, CancerTYPE ID®, and the launch of KRAS mutational testing.

2010-02-15 09:22:00

- Taking Steps to Preserve Liquidity - QUEBEC CITY, Feb. 15 /PRNewswire-FirstCall/ - DiagnoCure, Inc.

2010-02-09 07:30:00

SAN DIEGO, Feb. 9 /PRNewswire-FirstCall/ -- Sequenom, Inc. (Nasdaq: SQNM), today announced an exclusive worldwide licensing agreement with Optherion, Inc.

2010-01-14 16:44:00

QUEBEC CITY, Jan. 14 /PRNewswire-FirstCall/ - DiagnoCure Inc. (TSX: CUR), a life sciences company commercializing high-value cancer diagnostic tests and delivering lab services, today reported financial and operation results for the fourth quarter 2009 and fiscal year ended October 31, 2009.


Word of the Day
upstander
  • A person who stands up for something, as contrasted to a bystander who remains inactive.
  • One of the upright handlebars on a traditional Inuit sled.
The word 'upstander' in the first sense here is a play on the word 'bystander' and the idea of 'standing up' for something.